HAG regimen improves survival in adult patients with hypocellular acute myeloid leukemia

Item

http://www.wikidata.org/entity/Q36772225

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

HAG regimen improves survival in adult patients with hypocellular acute myeloid leukemia

@ast

HAG regimen improves survival in adult patients with hypocellular acute myeloid leukemia

@en

type

Item

label

HAG regimen improves survival in adult patients with hypocellular acute myeloid leukemia

@ast

HAG regimen improves survival in adult patients with hypocellular acute myeloid leukemia

@en

prefLabel

HAG regimen improves survival in adult patients with hypocellular acute myeloid leukemia

@ast

HAG regimen improves survival in adult patients with hypocellular acute myeloid leukemia

@en

P1476

HAG regimen improves survival in adult patients with hypocellular acute myeloid leukemia

@en

P2093

Hao Xi

http://www.w3.org/2001/XMLSchema#string

Huiying Qiu

http://www.w3.org/2001/XMLSchema#string

Jianmin Wang

http://www.w3.org/2001/XMLSchema#string

Jianmin Yang

http://www.w3.org/2001/XMLSchema#string

Jie Chen

http://www.w3.org/2001/XMLSchema#string

Lei Gao

http://www.w3.org/2001/XMLSchema#string

Li Chen

http://www.w3.org/2001/XMLSchema#string

Libing Wang

http://www.w3.org/2001/XMLSchema#string

Shuqin Lü

http://www.w3.org/2001/XMLSchema#string

Weijun Fu

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

Low dose of homoharringtonine and cytarabine combined with granulocyte colony-stimulating factor priming on the outcome of relapsed or refractory acute myeloid leukemia.

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patients.

Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach.

Homoharringtonine and omacetaxine for myeloid hematological malignancies.

P304

3623-3634

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.6211

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283262013

http://www.w3.org/2001/XMLSchema#string

P698

26497216

http://www.w3.org/2001/XMLSchema#string

P932

4823132

http://www.w3.org/2001/XMLSchema#string